Period of submission

Wednesday, September 30, 2026 – Monday, November 30, 2026 at 12:00 PM (JST)
*Notification of acceptance or rejection will be sent by email in mid-March 2027.

Type of Presentation

The presentation format will be Poster Presentation.

Abstract submission guidelines

• Please register by clicking the "abstract submission" button at the bottom of the page. Once the submission is completed, a confirmation email will be automatically sent. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (jspn123@m.congre.co.jp).
• You can revise your abstract as many times as you like during the abstract registration period.

Submission Guideline

• Title: up to 100 characters in single byte
• Body of abstract: up to 400 words in single byte
• Co-authors: up to 30 persons
• Affiliations: up to 10 affiliations

Five Pillars

The main theme of this Congress is “To Craft a Visionary Compass for the Future of Psychiatric and Medical Practice.”

With the aim of maintaining the universal care and high standards that Japanese mental health care is proud of, while envisioning activities that contribute to social development beyond the framework of medical care, the following Five Pillars will serve as the foundation of the Congress program and guide further discussion.

Please select one pillar that best corresponds to the content of your abstract.
For details on the Five Pillars, please refer to the relevant information page

1. Advancement of psychiatric care based on psychiatric research
2. Communication with society, including prevention in addition to diagnosis and treatment
   
3. Health education and awareness
4. Development of medical infrastructure to support these efforts
5. Protection of medical ethics and patient rights

Categories

Please choose the category for your paper.
*Up to 3 categories can be registered.
*You are required to choose at least 1 category.

01	Schizophrenia and related disorders	26	Neurochemistry
02	Mood disorders	27	Neuropathology
03	Neurotic disorders and related disorders	28	Genetics and molecular genetics
04	Personality disorders	29	Epidemiology
05	Epilepsy	30	Community mental health services
06	Dementia	31	Emergency psychiatry
07	Eating disorders-Behavioural syndromes associated with physiological disturbances and physical factors	32	Complications of physical illness in patients with mental illness
08	Organic and symptomatic mental disorders	33	Palliative care
09	Substance abuse and dependence	34	Consultation-liaison psychiatry
10	Mental disorders in childhood and adolescence	35	Early intervention
11	Perinatal mental health	36	Psychiatric diagnosis
12	Sleep disorders	37	Symptomatology
13	Mental retardation	38	Pharmacotherapy
14	Mental disorders in old age	39	Psychotherapy
15	Treatment-refractory severe mental disorders	40	Psychosocial therapy/psychoeducation
16	Gender and mental health	41	ECT/TMS/neuromodulation
17	Forensic psychiatry	42	Laboratory tests/biomarkers
18	Occupational mental health	43	Neuroimaging
19	Social psychiatry	44	Animal model/basic research
20	Mental health and welfare	45	Suicide prevention
21	Medical education	46	Disaster psychiatry
22	Psychopathology	47	Emerging infectious diseases (such as COVID-19)
23	Neuropsychology	48	AI
24	Neurophysiology	49	Psychiatric ethics
25	Psychopharmacology	50	Others

Personal Information Protection

Please read and agree to the "Handling of personal information" in the form.

Congress Secretariat

Congrès Inc.
Nakanoshima Qross 4-3-51 Nakanoshima, Kita-ku, Osaka 〒530-0005, Japan
E-mail: jspn123@m.congre.co.jp